Literature DB >> 24716174

The Effect of Cinnamon on Glucose of Type II Diabetes Patients.

Farzaneh Hasanzade1, Maryam Toliat2, Seyyed Ahmad Emami3, Zahra Emamimoghaadam4.   

Abstract

The incidence of type II diabetes is increasing across the world. Dietary modifications help the patients to control blood glucose. Traditional herbs and spices are commonly used for control of glucose among which cinnamon (Ròu Guì; Cinnamomum cassia) has the greatest effect. Research has shown that adding cinnamon to diet can help to lower the glucose level. The aim of this study was to determine the effect of cinnamon on the glucose level in blood. This was a Randomized clinical trial in which 70 Patients with type II diabetes were assigned randomly two groups (35 in cinnamon and 35 in placebo group). The groups were matched in terms of body mass index (BMI), HbAlc and fasting blood sugar (FBS). Patients were treated with cinnamon and the placebo group was treated with placebo in addition to their routine treatment for 60 days. FBG levels and glycosylated hemoglobin of patients on the first day, and 1 and 2 months after treatment were measured. Data were analyzed using t-test and paired t-test in Statistical Package for the Social Sciences (SPSS).16 software. The mean levels of FBS before, and 1 and 2 months after the intervention were 174 ± 59, 169 ± 43 and 177 ± 45; respectively. The levels of HbAlc before and after the intervention in the cinnamon group were (8.9 ± 1.7 and 8.9 ± 1.6). There was no significant difference in FBS and glycosylated hemoglobin levels between the two groups (P = 0.738 and P = 0.87, respectively). Results showed that using certain amount of cinnamon for 60 days did not change the glucose level of diabetic patients. So, using cinnamon to type II diabetes patients cannot be recommended and more studies are needed in future.

Entities:  

Keywords:  Cinnamon; Diabetes; Fasting blood sugar; Herbal medicine

Year:  2013        PMID: 24716174      PMCID: PMC3924990          DOI: 10.4103/2225-4110.114900

Source DB:  PubMed          Journal:  J Tradit Complement Med        ISSN: 2225-4110


INTRODUCTION

Prevalence of diabetes type II was increasing across the world. Studies showed that more than 220 million suffer from diabetes worldwide.[1] The WHO report in the year 2000, put the estimates at 171 million. Which is expected to rise to 366 million in 2030.[23] Diabetes mellitus is a chronic disorder of glucose metabolism resulting from dysfunction of pancreatic beta cells and insulin resistance. It is still a serious global health problem. The disease prevails in both genders and all age groups, so there is concern among the general public about its control and treatment. The therapeutic goal of diabetes control is reaching the normal level of blood glucose without hypoglycemia and without causing any disturbance in the daily life activities of patients. In type II diabetes, if the fasting blood sugar (FBS) cannot be controlled by diet, oral drugs are used for the control of blood glucose which is associated with side effects resulting from long – term drug use.[4] Using complementary medicine among patients with diabetes is different but the major therapies used among the patients are nutritional supplements, herbal medicines, spiritual therapies, relaxation techniques and Yoga.[5] Studies showed that most of the diabetic patients use herbal medicines more than the other supplemental therapies because they believe that herbal medicines are natural, and healthy, whereas in poor quality and with improper use, they can be harmful and cause adverse effects.[67] Many studies confirmed that complementary medicine could be effective for diabetic patients they cause decrease in blood glucose levels by different mechanisms that could be helpful in patients’ care and for their better quality of life.[8] Studies showed that spices such as cinnamon (Ròu Guì; Cinnamomum cassia), and carnation, walnut, green tea, and mint have similar effects on insulin action and the most active of them is cinnamon.[6] Cinnamon is the most bioactive product. Cinnamon is commonly used as a spice across the world and in Iran, its solution is used which is not toxic.[9] Several studies have been conducted to confirm the effect of cinnamon on decreasing the blood glucose of diabetic patients.[10] Khan[11] and Crawford[12] showed that cinnamon has anti- diabetic effect, but Steve Blevins[13] was not in agreement on the effect of cinnamon. In this respect, no study has been conducted in Iran on human subjects. Gheibi and Parvizi (2005) performed their study or rats and showed that cinnamon could decrease blood glucose in diabetes.[10] Therefore, keeping in mind the controversy on the effect of cinnamon in decreasing the blood glucose and due to the widespread use of cinnamon among Iranian people, this study was designed to see the effect of cinnamon on blood glucose in Type II diabetic individuals.

MATERIALS AND METHODS

Subjects

This study was a double blind randomized clinical trial that was done to determine the effect of cinnamon on the blood glucose of patients with diabetes type II in Mashhad. Samples were selected randomly and assigned to two groups of treatment and placebo. The study tools included demographic data, biochemistry auto analyzer, Pars Azmoon glucose kit and Bio-system kit. Validity of demographic form was confirmed by content validity and the other instruments used for measurement of blood glucose and glycosylated hemoglobin were valid. To determine a power of 0.80, we calculated a sample size of 70, with α = 0.05. The sample size in each group was 35 and the study duration was 2 months. The inclusions criteria were: Age > 18 years, no pregnancy, no acute and severe stern in recent 8 weeks, not intake of herbs or other complementary cinnamon in recent 8 weeks, HbAlc > 7, 140 < FBS < 250, no allergy or sensitivity to cinnamon or other foods, no history of hemolytic anemia or hemoglobinopathy, no acute infection (pneumonia, urinary tract infection, otitis) and no insulin therapy.

Study design and dietary intervention

Subjects were selected based on the inclusion criteria among the patients who came to the (Endocrinology and Metabolism Center, Mashhad University of Medical Science. The Samples selected and assigned randomly to two groups (treatment and placebo). We randomized the patients by blocking (a designed technique). Investigators and subjects were blinded to group assignment and to capsule content. Cinnamon and placebo were ground finely and put into capsules which could not be distinguished by color, odor, or taste. Each capsule contained 500 mg product. After explaining the research objectives to the patients and taking their consent, demographic and related data were collected by interview and using patient's medical file. Then, boxes of A and B that included 60 capsules of cinnamon (Cinnamomum cassia) or placebo, prepared by collage of pharmacy, were given to the patients. Patients had to use two capsules after breakfast and dinner with their drugs for first 30 days, then after 8h of fasting, 5 ml of blood was collected for glucose test. Then two capsules were given to patients for use for second 30 days and also, their blood glucose at the end of the second 30 days was evaluated. Thirty and sixty days after using capsules, necessary information such as change of drugs, cinnamon use, diet change, and Physical Activity was collected for the samples. Medications and diet of subjects were not changed during the study. Researcher used phone call for follow-up to ensure the use of capsules and recorded data about changing drug, diet and physical activity in a checklist. Researcher did not know the contents of the capsules until the end of the sampling and all the experiments were carried out by one laboratory. Compliance to the supplementation protocol was supervised by a research technician who contacted the subjects once a week. Each subject was required to return the original bottle of their respective supplement for capsule counts and compliance was monitored by counting the unconsumed capsules each week.

Statistical methods and data analysis

Data are presented as Mean ± SD or percentage. Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) software (version 11.5). The normal distribution of the variable was checked by Kolmogorov-Smirnov test. Qualitative variables, such as physical activity, were analyzed using Chi-square test. For comparison of variables before and after the intervention within each group, paired t test was used. Significant differences between groups were determined by using an independent t test. Statistical significance was set at P < 0.05.

RESULTS

The sample consisted of 70 Type II diabetes patients divided into two groups (35 cinnamon (Ròu Guì; Cinnamomum cassia) and 35 placebos). The mean age of patients was 54.3 ± 8.9 years. Of them, 33.8 % (24) were males and the rest were females. Most of the patients in the groups were housekeepers (65.8% and 58.3%, respectively in cinnamon and placebo groups). The mean of body mass index (BMI) in cinnamon and placebo groups was 27.1 and 28.4, respectively [Table 1]. There was no significant different between FBS and glycosylated hemoglobin in the two groups before the intervention [Table 2]. Results showed that there was no significant difference between the mean of blood glucose in 30 and 60 days after the intervention in the two group (P > 0. 05) [Table 3]. There was no significant different between FBS and glycosylated hemoglobin in the two groups after the intervention (P > 0.05).
Table 1

Baseline characteristics of the study population*

Table 2

Comparison of means of FBS and HbAlc in patients’ before and after the intervention period in the two groups

Table 3

Comparison of means of FBS in patients’ 30 and 60 days after the intervention in the two groups

Baseline characteristics of the study population* Comparison of means of FBS and HbAlc in patients’ before and after the intervention period in the two groups Comparison of means of FBS in patients’ 30 and 60 days after the intervention in the two groups

DISCUSSION

In this study, the blood glucose of type II diabetes patients did not decreased by using 1 g cinnamon (Ròu Guì; Cinnamomum cassia) during 60 days. There was no significant difference in FBS and glycosylated hemoglobin levels before and after the intervention between the two groups. In vitro studies have shown that cinnamon extract has increasing effect on Phosphorylation activity of insulin receptors and decreasing effect on tyrosine phosphatase activity, and so, it shows insulin-like properties.[14] Some studies have shown that cinnamon, like insulin hormone, inhibits glycogen synthase activity.[15] Vance Chonbic et al., (2005) studied the effect of cinnamon on blood glucose of 25 type II diabetics during menopause and showed that there was no significant difference in terms of FBS, glycosylated hemoglobin, glucose tolerance test, insulin concentration and serum lipids concentration on using 1.5 g cinnamon for 6 weeks.[16] Steave Belvin et al., (2007) reported that using cinnamon 1 g daily for 3 month had no significant effect on glucose, lipid, and HbAlc levels in type II diabetics.[13] Justin et al., (2007) reported that using cinnamon 1 g daily had no significant effect on HbAlc of 72 type I diabetics and the result was similar to that of our study.[17] Soni et al., (2009) in one study showed that using 2g cinnamon had significant effect on the blood glucose of type II diabetics after 40 days and the findings confirmed that cinnamon is an effective material in decreasing the blood glucose of diabetic patients, which was not similar to our study results.[16] The difference could be attributed to the fact that in Soni's study, the experimental groups were formed by only males, so probably, hormonal difference and more consumption of cinnamon could be effective in the control of glucose, but it has not been proven yet. Khan et al., studied the effects of 1, 3, and 6 g day of whole cinnamon powder on FBG and serum lipids in 60 people with poorly controlled type II diabetes from Pakistan. After 40 days of supplementation, FBG decreased by 18-29%, cholesterol by 12-26%, low density lipoprotein (LDL) cholesterol by 7-27%, and triacylglycerol decreased by 23-30%.[11] The result of our study was not similar with that of Khan and Craw ford, as it could be related to the difference in base of FBS, using no standard diet and short duration of intervention compared to the present study.[1112] On the other hand, the capsules were packaged in a local store and use these capsules were not controlled in terms of purity. The other weakness of Crawford's study in comparison with our study was lack of placebo group and blindness. Our study result was similar to those of Justin,[18] and Steve Blevin but different from the results of Crawford, Khan, and Soni's studies. Comparing the result of this study with those of others and considering their limitations, we can point as the limitations of the present study its duration (8 weeks) and dose of the cinnamon used (1 g per day). There are some studies with longer duration[19] and it would be better if we could have the possibility for continuing the intervention. Which was impossible because subjects had time limitations to come to the study center (Endocrinology and Metabolism Center, Mashhad University of Medical Sciences) and extension of time would have led to limited compliance. There are some studies that used more than 1 g per day cinnamon and have reported significant effects,[11] and it would be better if we could have another group with higher dose of cinnamon for comparing the doses, which was impossible because of financial limitations.

CONCLUSION

Taking cinnamon (Ròu Guì; Cinnamomum cassia) at a dose of 1 g daily for 30 and 60 days has no effect in decreasing the blood glucose of type II diabetes patients. Based on the controversial information obtained on the effect of cinnamon in decreasing the blood glucose, it can be said that race, life style, BMI, type of drugs, and duration of taking cinnamon influence diabetes treatment. Many studies have been done reporting different results and it seems the effect of cinnamon was different in various populations. The results of this study showed that cinnamon use at the study dose and duration was no effective and it is recommended to perform many studies in future with cinnamon at various doses and treatment duration.
  13 in total

Review 1.  Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2.

Authors:  B Mang; M Wolters; B Schmitt; K Kelb; R Lichtinghagen; D O Stichtenoth; A Hahn
Journal:  Eur J Clin Invest       Date:  2006-05       Impact factor: 4.686

3.  Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects.

Authors:  Joanna Hlebowicz; Gassan Darwiche; Ola Björgell; Lars-Olof Almér
Journal:  Am J Clin Nutr       Date:  2007-06       Impact factor: 7.045

4.  Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes.

Authors:  Steve M Blevins; Misti J Leyva; Joshua Brown; Jonelle Wright; Robert H Scofield; Christopher E Aston
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

5.  Italian oncology nurses' knowledge of complementary and alternative therapies: national survey.

Authors:  Antonietta Zanini; Rosanna Quattrin; Debora Goi; Barbara Frassinelli; Mateo Panariti; Ivana Carpanelli; Silvio Brusaferro
Journal:  J Adv Nurs       Date:  2008-05       Impact factor: 3.187

6.  A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes.

Authors:  K J Jarvill-Taylor; R A Anderson; D J Graves
Journal:  J Am Coll Nutr       Date:  2001-08       Impact factor: 3.169

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients.

Authors:  Kristof Vanschoonbeek; Bregje J W Thomassen; Joan M Senden; Will K W H Wodzig; Luc J C van Loon
Journal:  J Nutr       Date:  2006-04       Impact factor: 4.798

9.  The effect of cinnamon on A1C among adolescents with type 1 diabetes.

Authors:  Justin A Altschuler; Samuel J Casella; Todd A MacKenzie; Kevin M Curtis
Journal:  Diabetes Care       Date:  2007-04       Impact factor: 19.112

10.  Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial.

Authors:  Paul Crawford
Journal:  J Am Board Fam Med       Date:  2009 Sep-Oct       Impact factor: 2.657

View more
  10 in total

Review 1.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

2.  Protective effect of cinnamon on diabetic cardiomyopathy in nicotinamide-streptozotocin induced diabetic rat model.

Authors:  Chekkilla Uday Kumar; Singareddy Sreenivasa Reddy; Palla Suryanarayana; Madhoosudan A Patil; Periketi Madhusudana Chary; Putcha Uday Kumar; Geereddy Bhanuprakash Reddy
Journal:  J Diabetes Metab Disord       Date:  2022-01-21

3.  Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis.

Authors:  Kaushik Chattopadhyay; Haiquan Wang; Jaspreet Kaur; Gamze Nalbant; Abdullah Almaqhawi; Burak Kundakci; Jeemon Panniyammakal; Michael Heinrich; Sarah Anne Lewis; Sheila Margaret Greenfield; Nikhil Tandon; Tuhin Kanti Biswas; Sanjay Kinra; Jo Leonardi-Bee
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

4.  Stimulatory Effects of Cinnamon Extract (Cinnamomum cassia) during the Initiation Stage of 3T3-L1 Adipocyte Differentiation.

Authors:  Sang Gil Lee; Joanna A Siaw; Hye Won Kang
Journal:  Foods       Date:  2016-12-06

5.  Evaluation of relaxant responses properties of cinnamon essential oil and its major component, cinnamaldehyde on human and rat corpus cavernosum.

Authors:  Alev Onder; Didem Yilmaz-Oral; Igor Jerkovic; Alp Ozgur Akdemir; Serap Gur
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

6.  Effect of Aqueous Cinnamon Extract on the Postprandial Glycemia Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.

Authors:  Ana Paula Rachid; Margarida Moncada; Maria Fernanda de Mesquita; José Brito; Maria Alexandra Bernardo; Maria Leonor Silva
Journal:  Nutrients       Date:  2022-04-10       Impact factor: 6.706

7.  Assessment of the effeCt of lIfestyle iNtervention plus water-soluble ciNnAMon extract On loweriNg blood glucose in pre-diabetics, a randomized, double-blind, multicenter, placebo controlled trial: study protocol for a randomized controlled trial.

Authors:  Paul Crawford; Chuong Thai; Joshua Obholz; Jeffrey Schievenin; Mark True; Sachin A Shah; John Hallgren; Jill Clark; Danny Sharon
Journal:  Trials       Date:  2016-01-05       Impact factor: 2.279

Review 8.  An update on natural compounds in the remedy of diabetes mellitus: A systematic review.

Authors:  Hira Choudhury; Manisha Pandey; Chua Kui Hua; Cheah Shi Mun; Jessmie Koh Jing; Lillian Kong; Liang Yee Ern; Nik Ahmad Ashraf; Soohg Wai Kit; Tan Sin Yee; Mallikarjuna Rao Pichika; Bapi Gorain; Prashant Kesharwani
Journal:  J Tradit Complement Med       Date:  2017-11-29

Review 9.  Antioxidant Effects and Mechanisms of Medicinal Plants and Their Bioactive Compounds for the Prevention and Treatment of Type 2 Diabetes: An Updated Review.

Authors:  Jeremiah Oshiomame Unuofin; Sogolo Lucky Lebelo
Journal:  Oxid Med Cell Longev       Date:  2020-02-13       Impact factor: 6.543

10.  Cinnamon as Dietary Supplement Caused Hyperlipidemia in Healthy Rats.

Authors:  Xiaomin Huang; Haiyang Cai; Han Li; Yixun Su; Hui Li; Weihong Li; Chenju Yi; Brian G Oliver; Hui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-02       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.